{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:44:27Z","timestamp":1792089867315,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-02003-7","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:44:43Z","timestamp":1792086283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the potential of resveratrol-enriched cord mesenchymal stem cell derived exosomes in an in vitro Parkinson\u2019s model"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2103-6750","authenticated-orcid":false,"given":"Suhair Rami Mohammed","family":"Shamshir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-5818","authenticated-orcid":false,"given":"Gulen Melike","family":"Demirbolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7687-6082","authenticated-orcid":false,"given":"Sevim","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"2003_CR1","doi-asserted-by":"publisher","first-page":"5842","DOI":"10.3390\/ijms24065842","volume":"24","author":"Y Aleksandrova","year":"2023","unstructured":"Aleksandrova Y, Chaprov K, Podturkina A et al (2023) Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson\u2019s Disease Model by Alleviating Mitochondrial Dysfunction. Int J Mol Sci 24:5842. https:\/\/doi.org\/10.3390\/ijms24065842","journal-title":"Int J Mol Sci"},{"key":"2003_CR2","doi-asserted-by":"publisher","first-page":"11819","DOI":"10.1021\/acs.chemrev.9b00404","volume":"119","author":"A Aliyan","year":"2019","unstructured":"Aliyan A, Cook NP, Mart\u00ed AA (2019) Interrogating Amyloid Aggregates using Fluorescent Probes. Chem Rev 119:11819\u201311856. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00404","journal-title":"Chem Rev"},{"key":"2003_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/pharmaceutics17020147","volume":"17","author":"Y Chen","year":"2025","unstructured":"Chen Y, Qi W, Wang Z, Niu F (2025) Exosome Source Matters: A Comprehensive Review from the Perspective of Diverse Cellular Origins. Pharmaceutics 17:147. https:\/\/doi.org\/10.3390\/pharmaceutics17020147","journal-title":"Pharmaceutics"},{"key":"2003_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/life15020294","volume":"15","author":"M-C Chiang","year":"2025","unstructured":"Chiang M-C, Yang Y-P, Nicol CJB et al (2025) Resveratrol-Enhanced Human Neural Stem Cell-Derived Exosomes Mitigate MPP+-Induced Neurotoxicity Through Activation of AMPK and Nrf2 Pathways and Inhibition of the NLRP3 Inflammasome in SH-SY5Y Cells. Life 15:294. https:\/\/doi.org\/10.3390\/life15020294","journal-title":"Life"},{"key":"2003_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, Dehghankhold M, Ataei S et al (2018) Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics 10:57. https:\/\/doi.org\/10.3390\/pharmaceutics10020057","journal-title":"Pharmaceutics"},{"key":"2003_CR6","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1111\/ejn.14699","volume":"53","author":"S Feng","year":"2021","unstructured":"Feng S, Wang Z, Yuan Y et al (2021) Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson\u2019s disease. Eur J Neurosci 53:2946\u20132959. https:\/\/doi.org\/10.1111\/ejn.14699","journal-title":"Eur J Neurosci"},{"key":"2003_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","volume":"60","author":"MT Ibarra-Guti\u00e9rrez","year":"2023","unstructured":"Ibarra-Guti\u00e9rrez MT, Serrano-Garc\u00eda N, Orozco-Ibarra M (2023) Rotenone-Induced Model of Parkinson\u2019s Disease: Beyond Mitochondrial Complex I Inhibition. Mol Neurobiol 60:1929\u20131948. https:\/\/doi.org\/10.1007\/s12035-022-03193-8","journal-title":"Mol Neurobiol"},{"key":"2003_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1021\/acschemneuro.3c00571","volume":"15","author":"E Illes-Toth","year":"2024","unstructured":"Illes-Toth E, Rempel DL, Gross ML (2024) Exploration of Resveratrol as a Potent Modulator of \u03b1-Synuclein Fibril Formation. ACS Chem Neurosci 15:503\u2013516. https:\/\/doi.org\/10.1021\/acschemneuro.3c00571","journal-title":"ACS Chem Neurosci"},{"key":"2003_CR9","doi-asserted-by":"publisher","unstructured":"Ioghen OC, Ceafalan LC, Popescu BO (2023) SH-SY5Y cell line in vitro models for Parkinson disease research\u2014old practice for new trends. J Integr Neurosci 22. https:\/\/doi.org\/10.31083\/j.jin2201020","DOI":"10.31083\/j.jin2201020"},{"key":"2003_CR10","doi-asserted-by":"publisher","unstructured":"Isik S, Osman S, Yeman-Kiyak B et al (2025) Advances in neurodegenerative disease therapy: stem cell clinical trials and promise of engineered exosomes. CNS Neurosci Ther 31. https:\/\/doi.org\/10.1111\/cns.70577","DOI":"10.1111\/cns.70577"},{"key":"2003_CR11","doi-asserted-by":"publisher","first-page":"6548","DOI":"10.7150\/thno.74305","volume":"12","author":"Y Jia","year":"2022","unstructured":"Jia Y, Yu L, Ma T et al (2022) Small extracellular vesicles isolation and separation: Current techniques, pending questions and clinical applications. Theranostics 12:6548\u20136575. https:\/\/doi.org\/10.7150\/thno.74305","journal-title":"Theranostics"},{"key":"2003_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","volume":"12","author":"MS Kim","year":"2016","unstructured":"Kim MS, Haney MJ, Zhao Y et al (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 12:655\u2013664. https:\/\/doi.org\/10.1016\/j.nano.2015.10.012","journal-title":"Nanomedicine"},{"key":"2003_CR13","doi-asserted-by":"publisher","unstructured":"Kovalevich J, Langford D (2013) Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol 1078:9\u201321 https:\/\/doi.org\/10.1007\/978-1-62703-640-5_2","DOI":"10.1007\/978-1-62703-640-5_2"},{"key":"2003_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00204-014-1221-y","volume":"88","author":"MY Kumasaka","year":"2014","unstructured":"Kumasaka MY, Yajima I, Ohgami N et al (2014) Commentary to Krishna et al. (2014): Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water. Arch Toxicol 88:1185\u20131186. https:\/\/doi.org\/10.1007\/s00204-014-1221-y","journal-title":"Arch Toxicol"},{"key":"2003_CR15","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biomedicines9080918","volume":"9","author":"H-C Kung","year":"2021","unstructured":"Kung H-C, Lin K-J, Kung C-T, Lin T-K (2021) Oxidative Stress, Mitochondrial Dysfunction, and Neuroprotection of Polyphenols with Respect to Resveratrol in Parkinson\u2019s Disease. Biomedicines 9:918. https:\/\/doi.org\/10.3390\/biomedicines9080918","journal-title":"Biomedicines"},{"key":"2003_CR17","doi-asserted-by":"publisher","first-page":"10674","DOI":"10.1038\/s41598-017-11320-y","volume":"7","author":"T-P Li","year":"2017","unstructured":"Li T-P, Wong W-P, Chen L-C et al (2017) Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs). Sci Rep 7:10674. https:\/\/doi.org\/10.1038\/s41598-017-11320-y","journal-title":"Sci Rep"},{"key":"2003_CR16","doi-asserted-by":"publisher","unstructured":"Li C, Wang Z, Lei H, Zhang D (2023) Recent progress in nanotechnology-based drug carriers for resveratrol delivery. Drug Deliv 30. https:\/\/doi.org\/10.1080\/10717544.2023.2174206","DOI":"10.1080\/10717544.2023.2174206"},{"key":"2003_CR18","doi-asserted-by":"publisher","first-page":"9271","DOI":"10.1007\/s12035-025-04824-6","volume":"62","author":"X Li","year":"2025","unstructured":"Li X, Li W, Xie X et al (2025) ROS Regulate Rotenone-induced SH-SY5Y Dopamine Neuron Death Through Ferroptosis-mediated Autophagy and Apoptosis. Mol Neurobiol 62:9271\u20139289. https:\/\/doi.org\/10.1007\/s12035-025-04824-6","journal-title":"Mol Neurobiol"},{"key":"2003_CR19","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1080\/10715762.2018.1489128","volume":"52","author":"K-L Lin","year":"2018","unstructured":"Lin K-L, Lin K-J, Wang P-W et al (2018) Resveratrol provides neuroprotective effects through modulation of mitochondrial dynamics and ERK1\/2 regulated autophagy. Free Radic Res 52:1371\u20131386. https:\/\/doi.org\/10.1080\/10715762.2018.1489128","journal-title":"Free Radic Res"},{"key":"2003_CR20","doi-asserted-by":"publisher","first-page":"16701","DOI":"10.1021\/acsomega.0c01582","volume":"5","author":"G Midekessa","year":"2020","unstructured":"Midekessa G, Godakumara K, Ord J et al (2020) Zeta Potential of Extracellular Vesicles: Toward Understanding the Attributes that Determine Colloidal Stability. ACS Omega 5:16701\u201316710. https:\/\/doi.org\/10.1021\/acsomega.0c01582","journal-title":"ACS Omega"},{"key":"2003_CR21","doi-asserted-by":"publisher","first-page":"8484","DOI":"10.1038\/s41598-017-08921-y","volume":"7","author":"K Nagaishi","year":"2017","unstructured":"Nagaishi K, Mizue Y, Chikenji T et al (2017) Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy. Sci Rep 7:8484. https:\/\/doi.org\/10.1038\/s41598-017-08921-y","journal-title":"Sci Rep"},{"key":"2003_CR22","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3390\/pharmaceutics14091798","volume":"14","author":"Z N\u00e9meth","year":"2022","unstructured":"N\u00e9meth Z, Cs\u00f3ka I, Semnani Jazani R et al (2022) Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives. Pharmaceutics 14:1798. https:\/\/doi.org\/10.3390\/pharmaceutics14091798","journal-title":"Pharmaceutics"},{"key":"2003_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12951-024-02681-4","volume":"22","author":"Z Nouri","year":"2024","unstructured":"Nouri Z, Barfar A, Perseh S et al (2024) Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases. J Nanobiotechnol 22:463. https:\/\/doi.org\/10.1186\/s12951-024-02681-4","journal-title":"J Nanobiotechnol"},{"key":"2003_CR25","doi-asserted-by":"publisher","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F, Anichtchik O, Dening Y et al (2010) Progression of Parkinson\u2019s Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice. PLoS ONE 5:e8762. https:\/\/doi.org\/10.1371\/journal.pone.0008762","journal-title":"PLoS ONE"},{"key":"2003_CR24","doi-asserted-by":"publisher","first-page":"485102","DOI":"10.1088\/0957-4484\/25\/48\/485102","volume":"25","author":"R Pangeni","year":"2014","unstructured":"Pangeni R, Sharma S, Mustafa G et al (2014) Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson\u2019s disease by reducing oxidative stress. Nanotechnology 25:485102. https:\/\/doi.org\/10.1088\/0957-4484\/25\/48\/485102","journal-title":"Nanotechnology"},{"key":"2003_CR26","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"2003_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13287-019-1484-6","volume":"10","author":"G Qiu","year":"2019","unstructured":"Qiu G, Zheng G, Ge M et al (2019) Functional proteins of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther 10:359. https:\/\/doi.org\/10.1186\/s13287-019-1484-6","journal-title":"Stem Cell Res Ther"},{"key":"2003_CR28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2741\/e843","volume":"11","author":"R Ramachandran","year":"2019","unstructured":"Rajendran M, Ramachandran R (2019) Fisetin protects against rotenone-induced neurotoxicity through signaling pathway. Frontiers in Bioscience 11:843. https:\/\/doi.org\/10.2741\/e843","journal-title":"Front Biosci"},{"key":"2003_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM (2023) Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: A review of the literature. AIMS Neurosci 10:200\u2013231. https:\/\/doi.org\/10.3934\/Neuroscience.2023017","journal-title":"AIMS Neurosci"},{"key":"2003_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40360-025-00938-8","volume":"26","author":"D Ramesh","year":"2025","unstructured":"Ramesh D, Bakkannavar SM, Bhat VR et al (2025) Comparative study on drug encapsulation and release kinetics in extracellular vesicles loaded with snake venom L - amino acid oxidase. BMC Pharmacol Toxicol 26:98. https:\/\/doi.org\/10.1186\/s40360-025-00938-8","journal-title":"BMC Pharmacol Toxicol"},{"key":"2003_CR31","doi-asserted-by":"publisher","first-page":"117754","DOI":"10.1016\/j.biopha.2024.117754","volume":"182","author":"R Rana","year":"2025","unstructured":"Rana R, Devi SN, Bhardwaj AK et al (2025) Exosomes as nature\u2019s nano carriers: Promising drug delivery tools and targeted therapy for glioma. Biomed Pharmacother 182:117754. https:\/\/doi.org\/10.1016\/j.biopha.2024.117754","journal-title":"Biomed Pharmacother"},{"key":"2003_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet M-F (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106\u2013107:17\u201332. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.04.004","journal-title":"Prog Neurobiol"},{"key":"2003_CR33","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.2147\/IJN.S444582","volume":"18","author":"J Tian","year":"2023","unstructured":"Tian J, Han Z, Song D et al (2023) Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications. Int J Nanomed Volume 18:7923\u20137940. https:\/\/doi.org\/10.2147\/IJN.S444582","journal-title":"Int J Nanomed Volume"},{"key":"2003_CR34","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"O-B Tysnes","year":"2017","unstructured":"Tysnes O-B, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm 124:901\u2013905. https:\/\/doi.org\/10.1007\/s00702-017-1686-y","journal-title":"J Neural Transm"},{"key":"2003_CR35","doi-asserted-by":"publisher","unstructured":"Van der Koog L, Gandek TB, Nagelkerke A (2022) Liposomes and extracellular vesicles as drug delivery systems: a comparison of composition, pharmacokinetics, and functionalization. Adv Healthc Mater 11. https:\/\/doi.org\/10.1002\/adhm.202100639","DOI":"10.1002\/adhm.202100639"},{"key":"2003_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2011.02.025","volume":"304","author":"Y Wang","year":"2011","unstructured":"Wang Y, Xu H, Fu Q et al (2011) Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in Parkinsonian rats. J Neurol Sci 304:29\u201334. https:\/\/doi.org\/10.1016\/j.jns.2011.02.025","journal-title":"J Neurol Sci"},{"key":"2003_CR37","doi-asserted-by":"publisher","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles 13. https:\/\/doi.org\/10.1002\/jev2.12404","DOI":"10.1002\/jev2.12404"},{"key":"2003_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJM (2017) The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegener 12:10. https:\/\/doi.org\/10.1186\/s13024-017-0149-0","journal-title":"Mol Neurodegener"},{"key":"2003_CR39","doi-asserted-by":"publisher","first-page":"115481","DOI":"10.1016\/j.intimp.2025.115481","volume":"165","author":"K Ye","year":"2025","unstructured":"Ye K, Peng Q, Zhang Z et al (2025) Resveratrol primed adipose stem cell-derived exosomes alleviate intestinal ischemia reperfusion injury by regulating macrophage polarization. Int Immunopharmacol 165:115481. https:\/\/doi.org\/10.1016\/j.intimp.2025.115481","journal-title":"Int Immunopharmacol"},{"key":"2003_CR40","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1007\/s11033-023-08409-1","volume":"50","author":"MY Zamanian","year":"2023","unstructured":"Zamanian MY, Parra RMR, Soltani A et al (2023) Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson\u2019s disease: an overview and update on new developments. Mol Biol Rep 50:5455\u20135464. https:\/\/doi.org\/10.1007\/s11033-023-08409-1","journal-title":"Mol Biol Rep"},{"key":"2003_CR42","doi-asserted-by":"publisher","first-page":"123548","DOI":"10.1016\/j.biomaterials.2025.123548","volume":"325","author":"Y Zhu","year":"2026","unstructured":"Zhu Y, Xi Q, Liu Y et al (2026) Recent advances in exosome-based nanodelivery systems for Parkinson\u2019s disease. Biomaterials 325:123548. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123548","journal-title":"Biomaterials"},{"key":"2003_CR43","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/molecules25163731","volume":"25","author":"A Zieli\u0144ska","year":"2020","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM et al (2020) Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules 25:3731. https:\/\/doi.org\/10.3390\/molecules25163731","journal-title":"Molecules"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-02003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-02003-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-02003-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:44:44Z","timestamp":1792086284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-02003-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2003"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-02003-7","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"238"}}